Maximum quantity allowed is 999
CAS RN: 74711-43-6 | Product Number: Z0021
Zaltoprofen
Purity: >98.0%(T)(HPLC)
- 2-(10,11-Dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic Acid
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Product Number | Z0021 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__7H__1__4O__3S = 298.36 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Condition to Avoid | Light Sensitive |
Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image) |
CAS RN | 74711-43-6 |
Reaxys Registry Number | 6770548 |
PubChem Substance ID | 160871191 |
Merck Index (14) | 10112 |
MDL Number | MFCD00864323 |
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Melting point | 135.0 to 139.0 °C |
Melting Point | 137 °C |
Solubility in water | Insoluble |
Solubility (soluble in) | Methanol |
Solubility (slightly sol. in) | Benzene, Ethanol |
Pictogram | |
Signal Word | Warning |
Hazard Statements | H302 : Harmful if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
RTECS# | HQ2526700 |
H.S.code* | 2934.99-000 |
Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells
Zaltoprofen inhibits bradykinin-induced responses by blocking the activation of second messenger signaling cascades in rat dorsal root ganglion cells
H. Tang, A. Inoue, K. Oshita, K. Hirate, Y. Nakata, Neuropharmacology 2005, 48, 1035.
Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 1st Communication: Inhibitory effects on rat paw edema
K. Tsurumi, K. Kyuki, M. Niwa, S. Kokuba, H. Fujimura, Arzneim.-Forsch. 1986, 36, 1796.
Analgesic and antiinflammatory effects of 2-(10,11-dihydro-10-oxo-dibenzo[b,f]thiepin-2-yl)propionic acid in rat and mouse
T. Kameyama, T. Nabeshima, S. Yamada, M. Sato, Arzneim.-Forsch. 1987, 37, 19.
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.